000 01531 a2200373 4500
005 20250515003605.0
264 0 _c20060713
008 200607s 0 0 eng d
022 _a0931-0509
024 7 _a10.1093/ndt/gfi231
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRusso, Mark W
245 0 0 _aRandomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C.
_h[electronic resource]
260 _bNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
_cFeb 2006
300 _a437-43 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolyethylene Glycols
650 0 4 _aRecombinant Proteins
650 0 4 _aRenal Dialysis
700 1 _aGhalib, Reem
700 1 _aSigal, Samuel
700 1 _aJoshi, Viren
773 0 _tNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
_gvol. 21
_gno. 2
_gp. 437-43
856 4 0 _uhttps://doi.org/10.1093/ndt/gfi231
_zAvailable from publisher's website
999 _c15862426
_d15862426